You Have Everything, Yet Feel Nothing. Here's Why.

After serotonin does its job in your brain, it needs to be recycled back into the neuron so it can be used again. The SLC6A4 gene produces the protein that does this recycling. Think of it as a retrieval pump: it grabs used serotonin from the synapse and pulls it back into the cell. Without efficient recycling, serotonin gets depleted between uses.

The 5-HTTLPR short allele, carried by approximately 40% of the population, impairs this recycling process. The pump works, but it’s slower and less efficient. Serotonin stays in the synapse slightly longer, but you’re also losing more of it overall, which nets to a functional shortage. This variant is strongly associated with elevated anxiety reactivity, poor stress resilience, and persistent low mood that doesn’t respond well to willpower or circumstance change.

You might feel chronically tense, overreactive to small stressors, and persistently sad even on days where nothing bad happened. Your mood might feel thin, fragile, easily tipped toward emptiness. Standard doses of SSRIs (which block serotonin reuptake to increase availability) often work well for this variant, but require proper dosing to address the underlying inefficiency.

COMT breaks down dopamine, norepinephrine, and epinephrine (your motivation, focus, and stress hormones). Think of it as your nervous system’s cleanup crew. Once stress passes, COMT should clear the stress hormones quickly so you can return to baseline. If COMT is efficient, you recover fast. If it’s slow, stress hormones linger.

The Val158Met variant, found in roughly 25% of people as homozygous slow, reduces COMT activity significantly. Stress hormones clear more slowly from your system, keeping you in a low-level state of physiological stress even after the stressor is gone. You feel persistently on edge, reactive, and unable to relax. Dopamine also accumulates, which can paradoxically feel like anxiety or agitation rather than reward.

You might notice you can’t unwind after work even though the workday is over. Small frustrations feel disproportionately intense. You ruminate on small conflicts. Caffeine makes you feel wired rather than focused. Stimulating medications can push you into anxiety. Your mood improves when stress is genuinely low, but baseline stress tone is chronically elevated.

Before serotonin can do anything, it has to be made. TPH2 (tryptophan hydroxylase 2) is the enzyme that catalyzes the very first step of serotonin synthesis in the brain. It converts the amino acid tryptophan into 5-hydroxytryptophan, which then becomes serotonin. This is the rate-limiting step, meaning it’s the slowest part of the process. If TPH2 is slow, serotonin production becomes the bottleneck.

Variants in TPH2 reduce its activity. Roughly 20% of the population carries variants that impair this enzyme. Lower TPH2 activity means your brain makes less serotonin overall, creating a baseline shortage regardless of diet or supplementation. You’re starting from a lower pool of raw material, not just a recycling problem. This creates persistent low mood, difficulty feeling pleasure, and poor response to SSRIs (which can’t recycle serotonin efficiently if there isn’t much to begin with).

You might experience anhedonia (nothing feels rewarding), persistent flatness despite positive life events, and mood that feels inexplicably low even when you’ve optimized sleep, exercise, and diet. Tryptophan supplementation alone often isn’t enough because the bottleneck is at synthesis, not availability.

BDNF is growth factor for your brain. It signals neurons to grow new connections, repair damage, and adapt to new experiences. Without adequate BDNF, your brain gets stuck in existing patterns. You can’t learn your way out of depression the way others do. Neuroplasticity, the brain’s ability to rewire itself, depends on BDNF.

The Val66Met variant, carried by roughly 30% of the population, reduces BDNF secretion significantly. Your brain produces less of this critical growth factor, impairing its ability to form new neural connections and adapt to antidepressant treatment. This explains why some people respond to one course of therapy or medication, rewire their neural patterns, and feel better, while others stay stuck despite identical treatment. BDNF variants are particularly associated with treatment-resistant depression and poor response to both medication and psychotherapy.

You might find that therapy insights don’t seem to “stick” the way they do for others. You feel the same emotional patterns recurring despite genuine effort to change them. Antidepressants help less than expected. Exercise benefits plateau quickly. Your mood feels locked in place, resistant to the changes you consciously want to make.

MAOA breaks down serotonin, dopamine, and norepinephrine after they’ve been used. Think of it as your brain’s disposal system. Unlike COMT, which is fine-tuning, MAOA is the main clearing pathway for these neurotransmitters. If MAOA is very active, neurotransmitters get destroyed too fast, creating constant shortage. If MAOA is slow, neurotransmitters accumulate but fluctuate unpredictably.

The MAOA-L (low activity) variant, carried by roughly 30-40% of males and fewer females (the gene is X-linked), slows degradation of these neurotransmitters. Rather than steady levels, you experience fluctuating spikes and crashes of dopamine and serotonin, creating mood instability and heightened stress reactivity. This variant is associated with both depression and impulsivity, particularly in the context of stress. The unpredictable neurochemistry creates a baseline hypervigilance.

You might notice your mood is inconsistent: some days fine, other days dark for no external reason. Your emotions might feel intense and reactive. You might have trouble with impulse control or anger regulation. Stress hits harder and takes longer to recover from. Your mood feels like you’re on a neurochemical roller coaster rather than a stable baseline.

When you experience stress, your body releases cortisol, the stress hormone. Cortisol is supposed to help you respond to the threat, then be reabsorbed by cortisol receptors so stress response turns off. FKBP5 regulates how sensitive these receptors are. If receptors are sensitive, cortisol attaches and stress turns off. If they’re insensitive, cortisol lingers and stress response stays activated.

The rs1360780 variant, carried by roughly 30% of the population, impairs glucocorticoid receptor sensitivity. Your cortisol receptors are less responsive, so cortisol stays elevated longer after stress, keeping your nervous system locked in a vigilant state. This is particularly problematic if you experienced childhood stress or trauma, which can compound the genetic effect. Your stress response doesn’t recover normally; baseline activation stays elevated.

You might feel persistent dread or apprehension with no clear cause. Your body feels chronically tense. You startle easily. Recovery from stressful events takes much longer than it should. Sleep is restless. Your nervous system feels like it’s running a constant background alert. This gene variant is strongly associated with anxiety disorders and depression rooted in stress sensitivity, not serotonin shortage.